Skip to main content
. 2023 Oct 2;4(12):1648–1659. doi: 10.1038/s43018-023-00645-5

Fig. 1. Overview of study design and drug selection.

Fig. 1

a, Outline of the prospective observational study. b, Overview of the drug classes in the compound library based on their targets/mode of action. FDA, Food and Drug Administration; TNF, tumor necrosis factor; IDH, isocitrate dehydrogenase; PLK, polo-like kinase 1; TLR, Toll-like receptor; HGF, hepatocyte growth factor; PKC, protein kinase C.

Source data